Mesoblast Stock (NASDAQ: MESO) stock price, news, charts, stock research, profile.
Open | $6.76 |
Close | $6.85 |
Volume / Avg. | 96.23K / 157.17K |
Day Range | $6.60 - $6.89 |
52 Wk Range | 1.61 - 8.66 |
Market Cap | $776.41M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 0.96% |
Days to Cover | 7.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Other companies in Mesoblast’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL) and Silence Therapeutics (NASDAQ:SLN).
Mesoblast has a consensus price target of $6.25.
The stock price for Mesoblast (NASDAQ: MESO) is $6.8 last updated September 20, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Mesoblast.
Mesoblast’s Q4 earnings are confirmed for Thursday, November 28, 2024.
There is no upcoming split for Mesoblast.
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.